Cica Soothing Gel Cream Base

1. INCI & CAS

INCI: Madecassoside · CAS: 34540-22-2

2. Role in the formula

Madecassoside is a purified triterpene glycoside from Centella asiatica. The guide level is for cosmetic leave-on chassis, not a wound-healing drug claim.

3. Typical use levels (formulation guide)

• 0.1–0.3% is listed for gels and gel-creams.
• Serums may use the guide range 0.1–0.5% for the formula.

Dissolve into water or an approved solvent. Avoid a long high-heat hold after addition.

4. Regulatory sources & global compliance

• If CosIng lists Madecassoside, that listing remains ingredient information; check rules for the intended market and use.
• The framework in Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Madecassoside is used, to be assessed for the complete formula intended for sale.
• Confirm the actual Madecassoside grade from supplier documentation and check requirements where the product will be sold.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; no drug approval or OTC-monograph status follows from this guide while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; select packaging with the formula's oxidation sensitivity in mind; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Madecassoside highlights Centella marker.

• This ingredient reference provides no basis for drug effects, cures, or certification claims that go beyond the documented ingredient information.
• This Madecassoside listing cannot verify skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI & CAS

INCI: Centella Asiatica Extract · CAS: 84696-21-9

2. Role in the formula

Centella asiatica extract is used as a soothing botanical in leave-on gels and creams. Madecassoside content of the extract is supplier-specific and is not invented here.

3. Typical use levels (formulation guide)

• The gels use-level reference is 1–3% in this reference.
• The level shown for creams is 1–4% in this reference.
• The formulation record indicates 1–5% of the extract as supplied for serums in this reference.

Add in cool-down when the carrier is heat-sensitive. Guide pH about 5–6.

4. Regulatory sources & global compliance

• Use CosIng's information on Centella Asiatica Extract as a reference, then verify the specific grade and intended use under market rules.
• The finished-product provisions of Regulation (EC) No 1223/2009 require the complete cosmetic containing Centella Asiatica Extract to receive its own safety assessment for the specific product as it will be marketed.
• Confirm the received Centella Asiatica Extract grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; no drug approval or OTC-monograph status follows from this guide with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; for oxidation-sensitive formulas, consider an airless or pump pack; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic role of Centella Asiatica Extract is presented as Centella botanical.

• The listed information does not establish a drug effect, a clinical cure, or certification status not established for the SKU.
• The Centella Asiatica Extract entry should not be used to substantiate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Asiaticoside · CAS: 16830-15-2

2. Role in the formula

Asiaticoside is a Centella triterpene glycoside used as a second marker in cica-style cosmetic guides.

3. Typical use levels (formulation guide)

• Gels and creams: 0.1–0.3%

Same cool-down handling as other Centella glycosides.

4. Regulatory sources & global compliance

• Database information on Asiaticoside does not replace review of the supplied grade and finished product under market rules.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require an assessment addressing the safety of the finished product that contains Asiaticoside at the level of the finished cosmetic product.
• Confirm the received Asiaticoside grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The percentage is shown for cosmetic development; the note establishes neither drug approval nor OTC-monograph status while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; consider an airless or pump format when oxidation sensitivity warrants it; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• Supports the second Centella marker

• The formulation note cannot verify claims of drug activity, a clinical cure, or an undocumented product certification.
• This cosmetic entry naming Asiaticoside cannot verify whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.